Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials. Issue 5 (20th January 2021)
- Record Type:
- Journal Article
- Title:
- Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials. Issue 5 (20th January 2021)
- Main Title:
- Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials
- Authors:
- Garde, Aurore
Guibaud, Laurent
Goldenberg, Alice
Petit, Florence
Dard, Rodolphe
Roume, Joelle
Mazereeuw‐Hautier, Juliette
Chassaing, Nicolas
Lacombe, Didier
Morice‐Picard, Fanny
Toutain, Annick
Arpin, Stéphanie
Boccara, Olivia
Touraine, Renaud
Blanchet, Patricia
Coubes, Christine
Willems, Marjolaine
Pinson, Lucile
Van Kien, Philippe Khau
Chiaverini, Christine
Giuliano, Fabienne
Alessandri, Jean‐Luc
Mathieu‐Dramard, Michèle
Morin, Gilles
Bursztejn, Anne‐Claire
Mignot, Cyril
Doummar, Diane
Di Rocco, Frederico
Cornaton, Jenny
Nicolas, Claire
Gautier, Elodie
Luu, Maxime
Bardou, Marc
Sorlin, Arthur
Philippe, Christophe
Edery, Patrick
Rossi, Massimiliano
Carmignac, Virginie
Thauvin‐Robinet, Christel
Vabres, Pierre
Faivre, Laurence
… (more) - Abstract:
- Abstract: Megalencephaly‐CApillary malformation‐Polymicrogyria (MCAP) syndrome results from somatic mosaic gain‐of‐function variants in PIK3CA . Main features are macrocephaly, somatic overgrowth, cutaneous vascular malformations, connective tissue dysplasia, neurodevelopmental delay, and brain anomalies. The objectives of this study were to describe the clinical and radiological features of MCAP, to suggest relevant clinical endpoints applicable in future trials of targeted drug therapy. Based on a French collaboration, we collected clinical features of 33 patients (21 females, 12 males, median age of 9.9 years) with MCAP carrying mosaic PIK3CA pathogenic variants. MRI images were reviewed for 21 patients. The main clinical features reported were macrocephaly at birth (20/31), postnatal macrocephaly (31/32), body/facial asymmetry (21/33), cutaneous capillary malformations (naevus flammeus 28/33, cutis marmorata 17/33). Intellectual disability was present in 15 patients. Among the MRI images reviewed, the neuroimaging findings were megalencephaly (20/21), thickening of corpus callosum (16/21), Chiari malformation (12/21), ventriculomegaly/hydrocephaly (10/21), cerebral asymmetry (6/21) and polymicrogyria (2/21). This study confirms the main known clinical features that defines MCAP syndrome. Taking into account the phenotypic heterogeneity in MCAP patients, in the context of emerging clinical trials, we suggest that patients should be evaluated based on the mainAbstract: Megalencephaly‐CApillary malformation‐Polymicrogyria (MCAP) syndrome results from somatic mosaic gain‐of‐function variants in PIK3CA . Main features are macrocephaly, somatic overgrowth, cutaneous vascular malformations, connective tissue dysplasia, neurodevelopmental delay, and brain anomalies. The objectives of this study were to describe the clinical and radiological features of MCAP, to suggest relevant clinical endpoints applicable in future trials of targeted drug therapy. Based on a French collaboration, we collected clinical features of 33 patients (21 females, 12 males, median age of 9.9 years) with MCAP carrying mosaic PIK3CA pathogenic variants. MRI images were reviewed for 21 patients. The main clinical features reported were macrocephaly at birth (20/31), postnatal macrocephaly (31/32), body/facial asymmetry (21/33), cutaneous capillary malformations (naevus flammeus 28/33, cutis marmorata 17/33). Intellectual disability was present in 15 patients. Among the MRI images reviewed, the neuroimaging findings were megalencephaly (20/21), thickening of corpus callosum (16/21), Chiari malformation (12/21), ventriculomegaly/hydrocephaly (10/21), cerebral asymmetry (6/21) and polymicrogyria (2/21). This study confirms the main known clinical features that defines MCAP syndrome. Taking into account the phenotypic heterogeneity in MCAP patients, in the context of emerging clinical trials, we suggest that patients should be evaluated based on the main neurocognitive expression on each patient. Abstract : … (more)
- Is Part Of:
- Clinical genetics. Volume 99:Issue 5(2021)
- Journal:
- Clinical genetics
- Issue:
- Volume 99:Issue 5(2021)
- Issue Display:
- Volume 99, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 99
- Issue:
- 5
- Issue Sort Value:
- 2021-0099-0005-0000
- Page Start:
- 650
- Page End:
- 661
- Publication Date:
- 2021-01-20
- Subjects:
- clinical trial -- MCAP syndrome -- PIK3CA -- PROS
Medical genetics -- Periodicals
616.0420 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cge ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cge.13918 ↗
- Languages:
- English
- ISSNs:
- 0009-9163
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.287000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 16198.xml